Table 1 Clinical and epidemiological characteristics of the population with CAP
Variables | Group 1 (n = 68) | Group 2 (n = 88) | Group 3 (n = 49) |
|---|---|---|---|
Age in years, Median (Q1-Q3) | 65 (41–76) | 63 (40–76) | 3 (1–7) |
Males, n (%) | 28 (41.2) | 49 (55.7) | 29 (59.2) |
Received antibiotics in last 3 months, n (%) | 19 (27.9) | 10 (11.4) | 9 (18.4) |
Symptom duration, in days, Median (Q1-Q3) | 7 (4–15) | 6 (3–10) | 4 (2–8) |
Presence of comorbidities, n (%) | 37 (54.4) | 50 (56.8) | 2 (4.1) |
Chronic obstructive pulmonary disease | 24 (35.3) | 37 (42) | 0 |
History of convulsions in the last month | 0 | 3 (3.4) | 2 (4.1) |
Severe pneumoniaa, n (%) | 15 (22.1) | 26 (29.5) | 1 (2.0) |
Frequency of atypical bacteria, n (%) | |||
M. pneumoniae | 5 (10.9) | 4 (5.2) | 21 (43.8) |
C. pneumoniae | 3 (6.5) | 9 (11.7) | 6 (12.5) |
L. pneumophila | 3 (6.5) | 2 (2.6) | 5 (10.4) |
Length of hospital stay, in days, Median (Q1-Q3) | 6 (3–9) | 7 (4–10) | 4 (2–9) |
In-hospital death, n (%) | 0 | 8 (9.1) | 0 |